Pharma

German-based Ralf Jahns, MD at Research2Guidance, explains the role of different stakeholders in fighting COVID-19.

The HIMSS Media team gives a recap of recent headlines surrounding the FDA, COVID-19 and new digital health software products.

Also: Providence supporting COVID-19 patients at home with Xealth and Twistle; Lief Therapeutics incorporates DrChrono's Open API.

Dr. Yuri Maricich, chief medical officer at Pear Therapeutics, speaks on his company's experience bringing a digital therapeutic product through the regulator's experimental program for health software.

Somryst, a prescription digital therapeutic combining cognitive behavioral therapy and personalized sleep restriction, is the first software product to put the FDA's early Precertification Program framework through its paces. 

Chairman of the UAE’s IBC Group is working with the UK biotech research company, Vaxbio to launch an affordable vaccine that the company hopes to launch by the summer.

Experience the education, innovation and collaboration of the HIMSS Global Health Conference & Exhibition… virtually.

How is the coronavirus pandemic affecting you?

The platform will include an AI-enabled patient-engagement tool and smart pricing. 

After monitoring the situation for weeks, CEO Hal Wolf says the 2020 HIMSS Global Health Conference & Exhibition will not proceed as hoped, given the health risks posed to attendees.